# Nintedanib Capsules, 100 mg and 150 mg

NDC: 76282-786
Generic name: Nintedanib
Labeler / Manufacturer: EXELAN PHARMACEUTICALS INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260507

FDA application: ANDA212609

## Active ingredients

- NINTEDANIB ESYLATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76282-786"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76282-786
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=60d8104e-cb6c-4f4f-8159-95ed57346ffa